5 / XIIIth ANNUAL MEETING OF THE EU MANTLE CELL LYMPHOMA NETWORK

24 – 26 October 2013        Send to printer


Conference organizers

Igor Aurer, University of Zagreb, Croatia
Martin Dreyling, Ludwig Maximilians University of Munich, Germany


Work Schedule

Thursday, October 24th 2013

Phase II meeting (chair: V. Ribrag)

17.00 introduction - M. Dreyling, V. Ribrag

17.15 current/future phase II/III studies

R2 Benda - F. Zaya BERT - G. Hess T3 trial - St. Le Gouill New concepts - V. Ribrag

19.00 tour of the old city

20.00 Dinner

Friday, October 25th 2013

9.00 Welcome - M. Dreyling

9.15 MCL younger/role of TBI: an inter-study analysis - O. Hermine/E. Hoster

9.45 discussion

10.00 GOELAMS trial (+/- R maintenance) - S. Le Gouill

10.15 FIL trial - M. Ladetto

10.30 discussion

11.00 coffee break

11.30 MCL Younger II:” Triangle” trial - M. Dreyling

12:00 MCL elderly - H. Kluin-Nelemans

12.15 MRD - C. Pott

12.30 discussion

12:45 R-HAD - M. Dreyling

13.00 Lunch

14.00 Functional analysis of SOX11 - V. Amador

14:15 discussion

14.30 Independent regulation of Noxa mRNA protein - H. Horn

14:45 discussion

15.00 Landscape of somatic mutations - E. Campo

15:15 discussion

15.30 MCL and Hodgkin: common molecular pathways? - M. Hansmann

15:45 discussion

16.00 coffee break

16:30 SOX11 and Ki67 - W. Klapper

16:45 discussion

17.00 Targeting the IRF4/myc axis with lenalidomid - A. Moros

17:15 discussion

17:30 HSP90 inhibitor: molecular mechanism - O. Weigert

17:45 discussion

18.00 MCL elderly R2 - Ch. Stephan

19:00 discussion

20:00 Dinner

Saturday, October 26th 2013

8.00 Breakfast

8.00 Dutch MCL H75 study in younger patients - J. Doordujn

8:15 discussion

8:30 R-CHOP/R-IVAC/auto-HCT - M. Szymiczyk

8:45 discussion

9.00 R-BAC 500 - C. Visco

9.15 discussion

9.30 Molecular mechanism of acquired Ara-C resistance P. Klener

9:45 discussion

10.00 Coffee break

10.30 retrospective MCL survey - R. Aurer

10:45 discussion

11.00 MCL: Retrospective survey in Croatia - I. Aurer

11.15 discussion

11.30 ASCT +/- TBI in 1st line (PLRG retrospective study) - M. Szymiczyk

11:45 discussion

12.00 Business meeting European MCL Network

12.15 various

12.30 Lunch


Other details